Upgrade to SI Premium - Free Trial

Personalis, Inc. (PSNL)

9.67 -0.37 (3.69%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/11/26)

Latest Headlines

Personalis gets CE-IVD marking for blood collection kits in Europe June 9, 2026 6:02 AM - StreetInsider Personalis Enables Global Biopharma Support with CE-IVD Marked Specimen Collection Kits June 9, 2026 6:00 AM - BizWire Form 4 Personalis, Inc. For: Jun 04 Filed by: Tachibana Aaron June 5, 2026 8:20 PM - SEC Filing Form 144 Personalis, Inc. Filed by: Tachibana Aaron June 4, 2026 4:32 PM - SEC Filing Personalis Highlights Early Colorectal Cancer Recurrence Detection and Ultrasensitive MRD Performance Across a Broad Set of Tumor Types at ASCO 2026 June 2, 2026 6:00 AM - BizWire Form 4 Personalis, Inc. For: May 28 Filed by: Hall Christopher M May 29, 2026 8:45 PM - SEC Filing Form 4 Personalis, Inc. For: May 29 Filed by: Tachibana Aaron May 29, 2026 8:27 PM - SEC Filing Form 144 Personalis, Inc. Filed by: Tachibana Aaron May 29, 2026 4:26 PM - SEC Filing Form 144 Personalis, Inc. Filed by: Hall Christopher M May 28, 2026 5:13 PM - SEC Filing Personalis to Highlight Breadth of NeXT Personal® Ultra-Sensitive ctDNA Data at ASCO 2026 Annual Meeting, Including Podium Presentation from TRACERx Consortium May 26, 2026 6:00 AM - BizWire Form 8-K Personalis, Inc. For: May 19 May 20, 2026 4:04 PM - SEC Filing Personalis expands Medicare coverage for cancer test to pre-surgery monitoring May 20, 2026 6:00 AM - StreetInsider Personalis Secures Fourth Medicare Coverage Decision for NeXT Personal®, Expanding Breast Cancer Coverage to Pre-Surgical Treatment Monitoring May 20, 2026 6:00 AM - BizWire Form 4 Personalis, Inc. For: May 12 Filed by: EASTHAM KARIN May 14, 2026 5:10 PM - SEC Filing Form 4 Personalis, Inc. For: May 12 Filed by: BOWMAN A BLAINE May 14, 2026 5:09 PM - SEC Filing Form 4 Personalis, Inc. For: May 12 Filed by: WIDDER KENNETH J May 14, 2026 5:07 PM - SEC Filing Form 4 Personalis, Inc. For: May 12 Filed by: Shoff Lonnie May 14, 2026 5:07 PM - SEC Filing Form 4 Personalis, Inc. For: May 12 Filed by: Bloom Olivia Kyusuk May 14, 2026 5:05 PM - SEC Filing Form 4 Personalis, Inc. For: May 12 Filed by: MYERS WOODROW A JR May 14, 2026 5:03 PM - SEC Filing Personalis to Participate in Upcoming Investor Events May 14, 2026 4:01 PM - BizWire Form 8-K Personalis, Inc. For: May 12 May 13, 2026 4:52 PM - SEC Filing Form 8-K Personalis, Inc. For: May 12 May 13, 2026 4:03 PM - SEC Filing Personalis receives Medicare coverage for cancer test monitoring May 13, 2026 6:01 AM - StreetInsider Personalis Receives Medicare Coverage for NeXT Personal® for Immunotherapy Monitoring Across Late-stage Solid Tumors May 13, 2026 6:00 AM - BizWire Form SCHEDULE 13G Personalis, Inc. Filed by: Deep Track Capital, LP May 12, 2026 4:28 PM - SEC Filing Personalis (PSNL) PT Raised to $55 at Lake Street May 12, 2026 8:43 AM - StreetInsider Personalis (PSNL) PT Lowered to $9 at Morgan Stanley May 12, 2026 8:36 AM - StreetInsider Personalis (PSNL) PT Lowered to $11 at BTIG May 11, 2026 5:50 AM - StreetInsider Needham Reiterates Buy Rating on Personalis (PSNL) May 8, 2026 6:38 AM - StreetInsider Form S-3ASR Personalis, Inc. May 7, 2026 5:02 PM - SEC Filing Personalis, Inc. (PSNL) Misses Q1 EPS by 2c ; Offers Guidance May 7, 2026 4:47 PM - StreetInsider Form 10-Q Personalis, Inc. For: Mar 31 May 7, 2026 4:12 PM - SEC Filing Form 8-K Personalis, Inc. For: May 07 May 7, 2026 4:04 PM - SEC Filing Personalis Reports First Quarter Results and Recent Highlights May 7, 2026 4:01 PM - BizWire Personalis to Announce First Quarter 2026 Financial Results April 23, 2026 4:01 PM - BizWire Personalis presents clinical data on cancer monitoring technology at AACR April 21, 2026 6:01 AM - StreetInsider Personalis Highlights Clinical Impact of Ultrasensitive ctDNA Monitoring and New Therapy Resistance Tracking at AACR 2026 April 21, 2026 6:00 AM - BizWire Personalis (PSNL) PT Lowered to $10 at TD Cowen April 13, 2026 8:51 AM - StreetInsider Personalis and Collaborators to Highlight Ultrasensitive ctDNA Data and New Therapy Resistance Tracking Capabilities at AACR 2026 April 13, 2026 6:00 AM - BizWire Form SCHEDULE 13G/A Personalis, Inc. Filed by: T. Rowe Price Investment Management, Inc. April 8, 2026 3:26 PM - SEC Filing Form ARS Personalis, Inc. For: Dec 31 April 2, 2026 4:12 PM - SEC Filing Form DEFA14A Personalis, Inc. April 2, 2026 4:09 PM - SEC Filing Form DEF 14A Personalis, Inc. For: May 12 April 2, 2026 4:05 PM - SEC Filing Personalis to Participate in the 25th Annual Needham Virtual Conference April 1, 2026 4:01 PM - BizWire Form 4 Personalis, Inc. For: Mar 15 Filed by: Tachibana Aaron March 17, 2026 4:59 PM - SEC Filing Form 4 Personalis, Inc. For: Mar 15 Filed by: Moore Stephen Michael March 17, 2026 4:58 PM - SEC Filing Form 4 Personalis, Inc. For: Mar 15 Filed by: Hall Christopher M March 17, 2026 4:55 PM - SEC Filing Form 4 Personalis, Inc. For: Mar 15 Filed by: Chen Richard March 17, 2026 4:54 PM - SEC Filing Form 8-K Personalis, Inc. For: Mar 13 March 17, 2026 4:17 PM - SEC Filing Personalis promotes Dr. Richard Chen to president role March 17, 2026 4:00 PM - StreetInsider Personalis Appoints Dr. Richard Chen as President to Further Accelerate MRD Adoption March 17, 2026 4:00 PM - BizWire Personalis publishes breast cancer study in Journal of Clinical Oncology March 12, 2026 6:02 AM - StreetInsider Personalis Announces New Publication Advancing Neoadjuvant Treatment Monitoring in Breast Cancer with NeXT Personal® March 12, 2026 6:00 AM - BizWire Full Article List